Crossmark

Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma

Crossref DOI link: https://doi.org/10.1186/s12957-022-02846-1

Published Online: 2022-12-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Mingkun

Lv, Minzhi

Fang, Yuan

Zhuang, Aobo

Wu, Qian

Tong, Hanxing

Lu, Weiqi

Zhang, Yong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81702893)

Shanghai Municipal Health Commission (202140083, 202140083)
License Information

Text and Data Mining valid from 2022-12-20

Version of Record valid from 2022-12-20
More Information

Article History

Received: 7 August 2022

Accepted: 20 November 2022

First Online: 20 December 2022

Declarations

:

: The studies involving human participants were reviewed and approved by Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below